QQQ   375.08 (+0.65%)
AAPL   148.42 (+1.28%)
MSFT   308.09 (+0.26%)
FB   339.36 (+1.20%)
GOOGL   2,856.89 (+0.05%)
TSLA   871.09 (+0.11%)
AMZN   3,427.11 (-0.57%)
NVDA   223.50 (+0.58%)
BABA   173.45 (+3.97%)
NIO   39.97 (+0.91%)
CGC   13.46 (+1.97%)
GE   104.92 (+0.77%)
AMD   116.97 (+0.46%)
MU   67.25 (-0.01%)
T   25.44 (+0.43%)
F   15.58 (+0.13%)
ACB   6.96 (+0.58%)
DIS   170.78 (-0.21%)
PFE   42.06 (+1.79%)
BA   216.26 (-0.33%)
AMC   42.66 (-0.86%)
QQQ   375.08 (+0.65%)
AAPL   148.42 (+1.28%)
MSFT   308.09 (+0.26%)
FB   339.36 (+1.20%)
GOOGL   2,856.89 (+0.05%)
TSLA   871.09 (+0.11%)
AMZN   3,427.11 (-0.57%)
NVDA   223.50 (+0.58%)
BABA   173.45 (+3.97%)
NIO   39.97 (+0.91%)
CGC   13.46 (+1.97%)
GE   104.92 (+0.77%)
AMD   116.97 (+0.46%)
MU   67.25 (-0.01%)
T   25.44 (+0.43%)
F   15.58 (+0.13%)
ACB   6.96 (+0.58%)
DIS   170.78 (-0.21%)
PFE   42.06 (+1.79%)
BA   216.26 (-0.33%)
AMC   42.66 (-0.86%)
QQQ   375.08 (+0.65%)
AAPL   148.42 (+1.28%)
MSFT   308.09 (+0.26%)
FB   339.36 (+1.20%)
GOOGL   2,856.89 (+0.05%)
TSLA   871.09 (+0.11%)
AMZN   3,427.11 (-0.57%)
NVDA   223.50 (+0.58%)
BABA   173.45 (+3.97%)
NIO   39.97 (+0.91%)
CGC   13.46 (+1.97%)
GE   104.92 (+0.77%)
AMD   116.97 (+0.46%)
MU   67.25 (-0.01%)
T   25.44 (+0.43%)
F   15.58 (+0.13%)
ACB   6.96 (+0.58%)
DIS   170.78 (-0.21%)
PFE   42.06 (+1.79%)
BA   216.26 (-0.33%)
AMC   42.66 (-0.86%)
QQQ   375.08 (+0.65%)
AAPL   148.42 (+1.28%)
MSFT   308.09 (+0.26%)
FB   339.36 (+1.20%)
GOOGL   2,856.89 (+0.05%)
TSLA   871.09 (+0.11%)
AMZN   3,427.11 (-0.57%)
NVDA   223.50 (+0.58%)
BABA   173.45 (+3.97%)
NIO   39.97 (+0.91%)
CGC   13.46 (+1.97%)
GE   104.92 (+0.77%)
AMD   116.97 (+0.46%)
MU   67.25 (-0.01%)
T   25.44 (+0.43%)
F   15.58 (+0.13%)
ACB   6.96 (+0.58%)
DIS   170.78 (-0.21%)
PFE   42.06 (+1.79%)
BA   216.26 (-0.33%)
AMC   42.66 (-0.86%)
NYSE:TMO

Thermo Fisher Scientific Price Target, Predictions & Analyst Ratings

$594.27
+6.24 (+1.06 %)
(As of 10/19/2021 11:58 AM ET)
Add
Compare
Today's Range
$589.94
$596.91
50-Day Range
$537.26
$609.78
52-Week Range
$433.52
$616.93
Volume8,199 shs
Average Volume1.57 million shs
Market Capitalization$233.80 billion
P/E Ratio27.55
Dividend Yield0.18%
Beta0.74

Thermo Fisher Scientific (NYSE:TMO) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analyst Rating Consensus

Buy
Based on 19 Analyst Ratings

Analyst Price Target Consensus

$611.11

High PT$710.00
Average PT$611.11
Low PT$525.00
TypeCurrent
10/19/20 to 10/19/21
1 Month Ago
9/19/20 to 9/19/21
3 Months Ago
7/21/20 to 7/21/21
1 Year Ago
10/20/19 to 10/19/20
Consensus Rating
Buy
Buy
Buy
Buy
Strong Buy
1 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
15 Buy rating(s)
18 Buy rating(s)
18 Buy rating(s)
15 Buy rating(s)
Hold
3 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
2 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$611.11$553.78$542.26$452.27
Price Target Upside2.83% Upside11.97% Upside11.80% Upside11.18% Upside
Get Thermo Fisher Scientific Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for TMO and its competitors with MarketBeat's FREE daily newsletter.


Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Thermo Fisher Scientific (NYSE:TMO) vs. Its Competitors

TypeThermo Fisher ScientificMedical CompaniesS&P 500
Consensus Rating Score
2.89
2.72
2.56
Consensus RatingBuyBuyBuy
Price Target Upside144.46% Upside7.56% Upside
News Sentiment RatingNeutral News
Neutral News
Neutral News
MarketBeat
Community Rating
Outperform Votes
1002
84.27%
Underperform Votes
187
15.73%
Avg. Outperform Votes
178
67.42%
Avg. Underperform Votes
86
32.58%
Avg. Outperform Votes
830
69.46%
Avg. Underperform Votes
365
30.54%

Thermo Fisher Scientific (NYSE:TMO) Analyst Ratings History

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
10/14/2021Cowen
Boost Price TargetOutperform$655.00 ➝ $696.00+20.55%
9/23/2021The Goldman Sachs Group
UpgradeBuy ➝ Conviction-Buy
9/22/2021Benchmark
Robert Wasserman
Boost Price TargetPositive ➝ Buy$580.00 ➝ $650.00+8.06%
9/22/2021BTIG Research
Sung Ji
Boost Price TargetBuy$610.00 ➝ $700.00+17.25%
9/21/2021UBS Group
Boost Price TargetBuy$595.00 ➝ $670.00+13.52%
9/20/2021Jefferies Financial Group
Brandon Couillard
Initiated CoverageHold$540.00-9.16%
9/20/2021SVB Leerink
P. Souda
Boost Price TargetOutperform$600.00 ➝ $675.00+14.80%
9/20/2021KeyCorp
Paul Knight
Boost Price TargetOverweight$555.00 ➝ $710.00+18.97%
9/20/2021JPMorgan Chase & Co.
Boost Price TargetOverweight$600.00 ➝ $700.00+17.29%
9/20/2021Citigroup
Boost Price TargetNeutral$535.00 ➝ $620.00+3.89%
8/4/2021Argus
Boost Price TargetAverage ➝ Buy$530.00 ➝ $600.00+11.73%
6/23/2021Robert W. Baird
Boost Price TargetPositive ➝ Outperform$545.00 ➝ $550.00+11.74%
4/16/2021Evercore ISI
Boost Price TargetOutperform$525.00 ➝ $540.00+9.65%
3/8/2021Barclays
Initiated CoverageOverweight$525.00+17.48%
2/2/2021Stifel Nicolaus
Boost Price TargetBuy$530.00 ➝ $600.00+16.40%
2/2/2021Morgan Stanley
Boost Price TargetOverweight$535.00 ➝ $575.00+11.55%
1/12/2021Credit Suisse Group
Boost Price Target$556.00 ➝ $580.00+12.98%
12/16/2020Smith Barney Citigroup
DowngradeBuy ➝ Neutral
10/27/2020Needham & Company LLC
Stephen Unger
Boost Price TargetBuy$477.00 ➝ $539.00+11.73%
9/30/2020Atlantic Securities
Initiated CoverageOverweight$494.00+13.74%
9/11/2020Bank of America
Boost Price TargetBuy$460.00 ➝ $480.00+12.15%
7/15/2020Cleveland Research
UpgradeNeutral ➝ Buy
4/21/2020Wells Fargo & Company
Boost Price TargetEqual Weight$300.00 ➝ $340.00+3.92%
5/30/2019Wolfe Research
Initiated CoverageOutperform ➝ Outperform
3/22/2019Deutsche Bank Aktiengesellschaft
Boost Price TargetBuy ➝ Buy$275.00 ➝ $300.00+10.68%
(Data available from 10/19/2016 forward. View 10+ years of historical ratings with our analyst ratings screener.)












Thermo Fisher Scientific (NYSE:TMO) Analyst Ratings Frequently Asked Questions

What is Thermo Fisher Scientific's consensus rating and price target?

According to the issued ratings of 19 analysts in the last year, the consensus rating for Thermo Fisher Scientific stock is Buy based on the current 3 hold ratings, 15 buy ratings and 1 strong buy rating for TMO. The average twelve-month price target for Thermo Fisher Scientific is $611.11 with a high price target of $710.00 and a low price target of $525.00. Learn more on TMO's analyst rating history

Do Wall Street analysts like Thermo Fisher Scientific more than its competitors?

Analysts like Thermo Fisher Scientific stock more than the stock of other Medical companies. The consensus rating score for Thermo Fisher Scientific is 2.89 while the average consensus rating score for medical companies is 2.72. Learn more on how TMO compares to other companies

Do MarketBeat users like Thermo Fisher Scientific more than its competitors?

MarketBeat users like Thermo Fisher Scientific stock more than the stock of other Medical companies. 84.27% of MarketBeat users gave Thermo Fisher Scientific an outperform vote while medical companies recieve an average of 67.42% outperform votes by MarketBeat users.

Is Thermo Fisher Scientific being upgraded by Wall Street analysts?

Over the previous 90 days, Thermo Fisher Scientific's stock had 1 upgrade by analysts.

Does Thermo Fisher Scientific's stock price have much upside?

According to analysts, Thermo Fisher Scientific's stock has a predicted upside of 11.84% based on their 12-month price targets.

What analysts cover Thermo Fisher Scientific?

This page was last updated on 10/19/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.